Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes.
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies.
Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas.
Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation. Am J Hematol. 2005 Apr; 78(4):265-74.
View in:
PubMed
subject areas
Adolescent
Adult
Bone Marrow Transplantation
Chronic Disease
Female
Graft vs Host Disease
Humans
Incidence
Leukemia
Lymphoma
Male
Middle Aged
Multiple Myeloma
Prognosis
Risk Factors
Skin
Stem Cell Transplantation
Survival Analysis
Transplantation, Homologous
authors with profiles
Michael Bishop